Oxycodone extended release - Egalet

Drug Profile

Oxycodone extended release - Egalet

Alternative Names: AD ER oxycodone; EG-P114; Egalet-002; Opioid 2

Latest Information Update: 30 Mar 2016

Price : $50

At a glance

  • Originator Egalet
  • Class Morphine derivatives; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Pain

Most Recent Events

  • 22 Mar 2016 Egalet initiates a phase III trial for Pain (chronic low back pain) in USA (NCT02716857)
  • 01 Jan 2016 Egalet initiates enrolment in a phase III trial for Pain in USA (NCT02603705)
  • 25 Nov 2015 Egalet plans a phase III trial in Non-cancer pain in USA (NCT02603705)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top